An integrated method for optimized identification of effective natural inhibitors against SARS-CoV-2 3CLpro
Abstract The current severe situation of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has not been reversed and posed great threats to global health. Therefore, there is an urgent need to find out effective antiviral drugs. The 3-chymotry...
Enregistré dans:
Auteurs principaux: | Qi Liao, Ziyu Chen, Yanlin Tao, Beibei Zhang, Xiaojun Wu, Li Yang, Qingzhong Wang, Zhengtao Wang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e3bf5e01a58d45099b95da7f124881fa |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents
par: Vicky Mody, et autres
Publié: (2021) -
Natural Products-Based Drug Design against SARS-CoV-2 Mpro 3CLpro
par: Rai C. Silva, et autres
Publié: (2021) -
Oxidative stress transforms 3CLpro into an insoluble and more active form to promote SARS-CoV-2 replication
par: Liubing Du, et autres
Publié: (2021) -
Structural and Biochemical Analysis of the Dual Inhibition of MG-132 against SARS-CoV-2 Main Protease (Mpro/3CLpro) and Human Cathepsin-L
par: Elisa Costanzi, et autres
Publié: (2021) -
POTENTIAL OF CURATELLA AMARICANA L. AGAINST SARS-COV2: BIOAVAILABILITY, MOLECULAR SIMILARITY AND MOLECULAR DOCKING BETWEEN SECONDARY METABOLITES AND PROTEASE TYPE 3-CHYMOTRYPSIN (3CLPRO)
par: Marcano,Emildo, et autres
Publié: (2021)